DrMedHealth.com Launches National Telehealth Access for GLP-1 Medical Wellness Programs
DrMedHealth.com, a LegitScript-certified telehealth platform run by Public Health Solution LLC, has announced the nationwide availability of its GLP-1 medical weight loss programs, broadening access to licensed physicians and prescription-based weight management services for adults across the United States and Washington, DC.
This expansion occurs amidst increasing demand for GLP-1 therapies within medically supervised weight management contexts. DrMedHealth.com offers a fully compliant telehealth experience, enabling patients to complete a complimentary online health assessment, undergo evaluation by a licensed healthcare provider, and—when clinically suitable—initiate treatment without requiring in-person appointments. Health tracking apps like Shotlee can help monitor progress and adherence to treatment plans.
The majority of patients receive a response from a provider within 2 to 24 hours. Moreover, medications are shipped discreetly to their homes in as little as 2 to 4 days.
Through its nationwide network of providers, DrMedHealth.com provides access to FDA-approved GLP-1 medications, which include Wegovy Registered, Ozempic Registered, and Mounjaro Registered, alongside compounded alternatives such as semaglutide and tirzepatide. These are prepared by licensed U.S. compounding pharmacies. Treatment options are available in both injectable and oral forms, allowing providers to customize treatment strategies according to each patient’s medical background, preferences, and specific clinical requirements.
Program Features and Benefits
Programs begin at a monthly cost of $249, which encompasses:


